5IV4 image
Deposition Date 2016-03-18
Release Date 2016-08-17
Last Version Date 2024-11-20
Entry Detail
PDB ID:
5IV4
Keywords:
Title:
Crystal structure of the human soluble adenylyl cyclase in complex with the allosteric inhibitor LRE1
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.79 Å
R-Value Free:
0.20
R-Value Work:
0.15
R-Value Observed:
0.16
Space Group:
P 63
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Adenylate cyclase type 10
Gene (Uniprot):ADCY10
Chain IDs:A
Chain Length:475
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CME A CYS modified residue
Primary Citation
Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase.
Nat.Chem.Biol. 12 838 844 (2016)
PMID: 27547922 DOI: 10.1038/nchembio.2151

Abstact

The prototypical second messenger cAMP regulates a wide variety of physiological processes. It can simultaneously mediate diverse functions by acting locally in independently regulated microdomains. In mammalian cells, two types of adenylyl cyclase generate cAMP: G-protein-regulated transmembrane adenylyl cyclases and bicarbonate-, calcium- and ATP-regulated soluble adenylyl cyclase (sAC). Because each type of cyclase regulates distinct microdomains, methods to distinguish between them are needed to understand cAMP signaling. We developed a mass-spectrometry-based adenylyl cyclase assay, which we used to identify a new sAC-specific inhibitor, LRE1. LRE1 bound to the bicarbonate activator binding site and inhibited sAC via a unique allosteric mechanism. LRE1 prevented sAC-dependent processes in cellular and physiological systems, and it will facilitate exploration of the therapeutic potential of sAC inhibition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures